Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO
"The TechWald acquisition and corporate restructure offer a unique opportunity for us to increase focus and accelerate performance.
- "The TechWald acquisition and corporate restructure offer a unique opportunity for us to increase focus and accelerate performance.
- In addition to the appointment of Sandweg, the company also appointed a new Board of Directors led by Executive Board Chair, Chris Richardson.
- Richardson currently serves as CEO for SafeHeal™, a leading innovator in the field of digestive surgery and developer of the Colovac device.
- Prior to that, Richardson served as President and CEO of Keystone Heart which was acquired by Venus Medtech in 2018.